Verona Pharma To Report First Quarter 2025 Financial Results And Provide Corporate Update
ReutersApr 15, 2025 10:03 AM
Verona Pharma PLC I9SAy.F:
VERONA PHARMA TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE
Further company coverage: [I9SAy.F]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
What is a Spot ETF for Altcoins? Which Tokens Might the SEC Approve for Spot ETFs?
a spot ETF for altcoins tracks the prices of altcoins and can be traded on stock exchanges. Once approved, these ETFs will be listed on platforms like Nasdaq and the New York Stock Exchange, not just on cryptocurrency exchanges like Coinbase and Binance.TradingKey
an hour ago
Understanding the U.S. Fiscal Framework: Is Trump’s Tariff-for-Tax-Cut Strategy Viable?
TradingKey – With the U.S. Senate and House of Representatives passing the budget resolution for President Donald Trump's second administration (Trump 2.0), his fiscal blueprint—centered on tax cuts, slashing government spending, and debt reduction—is moving forward. However, with federal debt at...TradingKey
3 hours ago
Buffett’s Billion-Yen Bet: Why Global Capital Is Flowing Into Japan
TradingKey - Since April, the Nikkei 225 has surged from 32,000 to nearly 38,000 points—a 15% gain that sharply outpaces the S&P 500’s performance over the same period. Beyond the uptick in local investor engagement, global funds have also renewed their interest in Japan’s markets.TradingKey
4 hours ago
What Are Zero-Day Expiration(0DTE) Options? How Do They Affect U.S. Stock Market Volatility Including VIX Index?
TradingKey - In recent years, whenever the U.S. stock market experiences sharp volatility, it not only sees a rise in the VIX Index but also a surge in trading of zero-day-to-expiration options (0DTE). These instruments have frequently been blamed by media outlets for exacerbating market swings.TradingKey
Wed, Apr 16
